Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Drug Discovery

Development and Preclinical Studies of Broad-Spectrum Anti-Hiv Agent (3′r,4′r)-3-Cyanomethyl-4-Methyl-3′,4′-Di-O-(S)-Camphanoyl-(+)-Cis-Khellactone (3-Cyanomethyl-4-Methyl-Dck)

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2008

English

Extremely Potent Orally Active Benzo[g]quinoline Analogue of the Dopaminergic Prodrug: 1-Propyl-Trans-2,3,4,4a,5,7,8,9,10,10a-Decahydro-1h-Benzo-[G]quinolin-6-One.

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2006

English

Potent and Selective Α-Ketoheterocycle-Based Inhibitors of the Anandamide and Oleamide Catabolizing Enzyme, Fatty Acid Amide Hydrolase

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2007

English

Selective Tight Binding Inhibitors of Trypanosomal Glyceraldehyde-3-Phosphate Dehydrogenase via Structure-Based Drug Design

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

1998

English

Enantiomeric Propanolamines as selectiveN-Methyl-d-aspartate 2B Receptor Antagonists†

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2008

English

Synthesis and Biological Activity of a Gemcitabine Phosphoramidate Prodrug

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2007

English

Discovery of Substituted 4-(Pyrazol-4-Yl)-Phenylbenzodioxane-2-Carboxamides as Potent and Highly Selective Rho Kinase (ROCK-II) Inhibitors

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2008

English

Gold(I) Analogues of a Platinum−Acridine Antitumor Agent Are Only Moderately Cytotoxic but Show Potent Activity againstMycobacterium Tuberculosis

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2009

English

Analysis of Peptide−Protein Binding Using Amino Acid Descriptors: Prediction and Experimental Verification for Human Histocompatibility Complex HLA-A*0201

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2005

English

Antitumor Agents 259. Design, Syntheses, and Structure−Activity Relationship Study of Desmosdumotin C Analogs

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2007

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Drug Discovery

Development and Preclinical Studies of Broad-Spectrum Anti-Hiv Agent (3′r,4′r)-3-Cyanomethyl-4-Methyl-3′,4′-Di-O-(S)-Camphanoyl-(+)-Cis-Khellactone (3-Cyanomethyl-4-Methyl-Dck)

Extremely Potent Orally Active Benzo[g]quinoline Analogue of the Dopaminergic Prodrug: 1-Propyl-Trans-2,3,4,4a,5,7,8,9,10,10a-Decahydro-1h-Benzo-[G]quinolin-6-One.

Potent and Selective Α-Ketoheterocycle-Based Inhibitors of the Anandamide and Oleamide Catabolizing Enzyme, Fatty Acid Amide Hydrolase

Selective Tight Binding Inhibitors of Trypanosomal Glyceraldehyde-3-Phosphate Dehydrogenase via Structure-Based Drug Design

Enantiomeric Propanolamines as selectiveN-Methyl-d-aspartate 2B Receptor Antagonists†

Synthesis and Biological Activity of a Gemcitabine Phosphoramidate Prodrug

Discovery of Substituted 4-(Pyrazol-4-Yl)-Phenylbenzodioxane-2-Carboxamides as Potent and Highly Selective Rho Kinase (ROCK-II) Inhibitors

Gold(I) Analogues of a Platinum−Acridine Antitumor Agent Are Only Moderately Cytotoxic but Show Potent Activity againstMycobacterium Tuberculosis

Analysis of Peptide−Protein Binding Using Amino Acid Descriptors: Prediction and Experimental Verification for Human Histocompatibility Complex HLA-A*0201

Antitumor Agents 259. Design, Syntheses, and Structure−Activity Relationship Study of Desmosdumotin C Analogs